Addex Therapeutics Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
ADXN
- Investments
-
1
- Share Price
-
$0.04
- (As of Friday Closing)
Addex Therapeutics General Information
Description
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
Contact Information
Website
www.addextherapeutics.comCorporate Office
- Chemin Des Aulx 12
- Case postale 68
- 1228 Plan-Les-Ouates
- Switzerland
Corporate Office
- Chemin Des Aulx 12
- Case postale 68
- 1228 Plan-Les-Ouates
- Switzerland
Addex Therapeutics Stock Performance
As of 13-Nov-2026, Addex Therapeutics’s stock price is $0.04. Its current market cap is $8.1M with 210M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.04 | $0.04 | $0.02 - $0.09 | $8.1M | 210M | 1.48M | -$0.06 |
Addex Therapeutics Financials Summary
As of 30-Jun-2026, Addex Therapeutics has a trailing 12-month revenue of $37.8K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 6,562 | 7,645 | 2,565 | 1,240 |
| Revenue | 38 | 36 | 459 | 1,794 |
| EBITDA | (8,600) | (8,220) | (5,287) | (2,508) |
| Net Income | (8,657) | (8,095) | 8,013 | (11,743) |
| Total Assets | 4,309 | 8,037 | 11,818 | 5,526 |
| Total Debt | 96 | 44 | 46 | 410 |
Addex Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Addex Therapeutics Comparisons
Industry
Financing
Details
Addex Therapeutics Competitors (59)
One of Addex Therapeutics’s 59 competitors is Arcus Biosciences, a Formerly VC-backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arcus Biosciences | Formerly VC-backed | Hayward, CA | ||||
| AC Immune | Formerly VC-backed | Lausanne, Switzerland | ||||
| Axsome Therapeutics | Formerly VC-backed | New York, NY | ||||
| Denali Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Alzinova | Corporation | Gothenburg, Sweden |
Addex Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Addex Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Addex Therapeutics Investments (1)
Addex Therapeutics’s most recent deal was a Later Stage VC with Stalicla for . The deal was made on 30-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Stalicla | 30-Jun-2025 | Later Stage VC | Drug Discovery |
Addex Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Addex Therapeutics FAQs
-
When was Addex Therapeutics founded?
Addex Therapeutics was founded in 2002.
-
Where is Addex Therapeutics headquartered?
Addex Therapeutics is headquartered in Plan-Les-Ouates, Switzerland.
-
What is the size of Addex Therapeutics?
Addex Therapeutics has 3 total employees.
-
What industry is Addex Therapeutics in?
Addex Therapeutics’s primary industry is Drug Discovery.
-
Is Addex Therapeutics a private or public company?
Addex Therapeutics is a Public company.
-
What is Addex Therapeutics’s stock symbol?
The ticker symbol for Addex Therapeutics is ADXN.
-
What is the current stock price of Addex Therapeutics?
As of 13-Nov-2026 the stock price of Addex Therapeutics is $0.04.
-
What is the current market cap of Addex Therapeutics?
The current market capitalization of Addex Therapeutics is $8.1M.
-
What is Addex Therapeutics’s current revenue?
The trailing twelve month revenue for Addex Therapeutics is $37.8K.
-
Who are Addex Therapeutics’s competitors?
Arcus Biosciences, AC Immune, Axsome Therapeutics, Denali Therapeutics, and Alzinova are some of the 59 competitors of Addex Therapeutics.
-
What is Addex Therapeutics’s annual earnings per share (EPS)?
Addex Therapeutics’s EPS for 12 months was -$0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
